These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 13801442)

  • 1. [Lupus erythematosus or a disease simulating lupus erythematosus developing following triantoin therapy].
    BLEHOVA B; DANESOVA J; MILUNICOVA A; STOLZ J
    Cesk Pediatr; 1959 Jul; 14():654-7. PubMed ID: 13801442
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lymphadenopathy following triantoin in audiogenic epilepsy].
    POKORNA M; ROSSLER M
    Cesk Pediatr; 1962 Apr; 17():354-8. PubMed ID: 14487454
    [No Abstract]   [Full Text] [Related]  

  • 3. Lupus erythematosus disseminatus after administration of mesantoin; report of two cases.
    LINDQVIST T
    Acta Med Scand; 1957 Aug; 158(2):131-8. PubMed ID: 13457840
    [No Abstract]   [Full Text] [Related]  

  • 4. [Apropos of neurological complications of the treatment of epilepsy by hydantoins].
    ROGER J; SOULAYROL R
    Rev Neurol (Paris); 1959 Jun; 100():783-5. PubMed ID: 14438340
    [No Abstract]   [Full Text] [Related]  

  • 5. [Relation of hydantoin preparations to the development of disseminated lupus erythematosus].
    Strejcek J; Hrbková M
    Cas Lek Cesk; 1965 Oct; 104(42):1158-61. PubMed ID: 5850713
    [No Abstract]   [Full Text] [Related]  

  • 6. Systemic lupus erythematosus caused by hydantoin preparations.
    Szegedi G; Petrányi G
    Ann Immunol Hung; 1972; 16(0):433-44. PubMed ID: 4607152
    [No Abstract]   [Full Text] [Related]  

  • 7. [LUPUS ERYTHEMATOSIS SYNDROME FOLLOWING PROLONGED HYDANTOIN THERAPY].
    SCHUETZ E; FRENGER W
    Med Klin; 1965 Apr; 60():537-41. PubMed ID: 14273807
    [No Abstract]   [Full Text] [Related]  

  • 8. [General review of the toxic side-effects caused by hydantoin derivatives used in epilepsy].
    FACCHETTI G
    Cervello G Nevrol; 1962 Mar; 38():147-60. PubMed ID: 13891254
    [No Abstract]   [Full Text] [Related]  

  • 9. [Neural and endocrine complications in the treatment of epilepsy with hydantoins].
    VERGER P
    J Med Bord; 1952 May; 129(5):425-6. PubMed ID: 14938802
    [No Abstract]   [Full Text] [Related]  

  • 10. [Case of agranulocytosis occurring during mesantoin therapy of epilepsy].
    RIGOTTI S
    Riv Neurol; 1951; 21(6):532-8. PubMed ID: 14942315
    [No Abstract]   [Full Text] [Related]  

  • 11. Dilantin toxicity. A clinical and electroence-phalographic study.
    ROSEMAN E
    Neurology; 1961 Oct; 11():912-21. PubMed ID: 13743310
    [No Abstract]   [Full Text] [Related]  

  • 12. [PROVOCATING FACTORS IN SYSTEMIC LUPUS ERYTHEMATOSUS (WITH REFERENCE TO THERAPEUTIC AGENTS)].
    VACHTENHEIM J
    Z Gesamte Inn Med; 1963 Sep; 18():842-9. PubMed ID: 14095014
    [No Abstract]   [Full Text] [Related]  

  • 13. [Granulocytopenic syndromes in mesantoin therapy].
    BELSASSO M; BONIVENTO M
    Minerva Med; 1952 Oct; 43(79):558-62. PubMed ID: 13013023
    [No Abstract]   [Full Text] [Related]  

  • 14. [Systemic lupus erythematosus caused by anticonvulsants].
    Szegedi G
    Orv Hetil; 1971 Oct; 112(44):2637-42. PubMed ID: 5133650
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical and experimental data on goiters with hypothyroidism induced by dimethyldithiohydantoin].
    GUINET P; BERGER M
    Ann Endocrinol (Paris); 1951; 12(4):544-8. PubMed ID: 14878226
    [No Abstract]   [Full Text] [Related]  

  • 16. [Side-effect of hydantion; therapy in the framework of visceral lupus erythematosus].
    RUPPLI H; VOSSEN R
    Schweiz Med Wochenschr; 1957 Dec; 87(51):1555-8. PubMed ID: 13519107
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lupus erythematosus and tuberculosis; a statistical comparison between lupus erythematosus and vulgaris].
    WAGNER G
    Arch Klin Exp Dermatol; 1955; 200():408-16. PubMed ID: 13249441
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of adults for epilepsy; toxic effect of 3-methyl 5-5-phenylethylhydantoin.
    BAILEY AA; WORDEN RE
    Proc Staff Meet Mayo Clin; 1949 Sep; 24(19):483-6. PubMed ID: 18138747
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemopoietic complications of hydantoin therapy of epilepsy].
    MANNHEIMER E; PAKESCH F; REIMER EE; VETTER H
    Med Klin; 1952 Oct; 47(42):1397-1401. PubMed ID: 13001915
    [No Abstract]   [Full Text] [Related]  

  • 20. [The relationship between epilepsy, systemic lupus erythematosus and anticonvulsant therapy].
    Leövey A; Petrányi G; Gyula S
    Orv Hetil; 1966 Sep; 107(38):1785-6. PubMed ID: 5974945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.